Search Research

With a Little Help From My Friends: Seeking Consistent and Persuasive Evidence - PubMed

With a Little Help From My Friends: Seeking Consistent and Persuasive Evidence

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

With a Little Help From My Friends: Seeking Consistent and Persuasive Evidence - PubMed

Fluid Resuscitation of the Adult Trauma Patient: Where Have We Been and Where Are We Going? - PubMed

The resuscitation of an adult trauma patient has been researched and written about for the past century. Throughout those discussions, 2 major controversies persist when discussing resuscitation methods: (1) the ideal choice of fluid type to use during the initial resuscitation period, and (2) the i …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Fluid Resuscitation of the Adult Trauma Patient: Where Have We Been and Where Are We Going? - PubMed

Hostage to History: The Duration of Antimicrobial Treatment for Acute Streptococcal Pharyngitis - PubMed

Oral antimicrobial treatment of acute streptococcal pharyngitis commonly is given for 10 days. An investigation was conducted of journal publications and textbooks from the dawn of the antimicrobial era to the present in order to discover the basis for this settled practice. Current treatment durati …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Hostage to History: The Duration of Antimicrobial Treatment for Acute Streptococcal Pharyngitis - PubMed

Oral Rehydration Therapy-20th Century Wonder - PubMed

Oral Rehydration Therapy-20th Century Wonder

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Oral Rehydration Therapy-20th Century Wonder - PubMed

[Venom as a cure--some notes on ancient medicine] - PubMed

Very little is known today about the linguistics and facts relating to venoms in the ancient world. The article concerns itself initially with the terminology: How were venoms conceptualized and what position did they occupy among medicines and other poisons? Additionally ancient knowledge of the co …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

[Venom as a cure--some notes on ancient medicine] - PubMed

Thirty years of phase I radiochemotherapy trials: Latest development - PubMed

Radiochemotherapy is undergoing a complete expansion. Currently, possibilities of treatment combination are skyrocketting, with different anticancer and targeted molecules, different radiotherapy techniques, and dose escalation with each therapy. The development of a modern phase I radiochemotherapy …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Thirty years of phase I radiochemotherapy trials: Latest development - PubMed

Target-Controlled Infusions: Surfing USA Redux - PubMed

Target-Controlled Infusions: Surfing USA Redux

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Target-Controlled Infusions: Surfing USA Redux - PubMed

Controlled Drug Delivery: Historical perspective for the next generation - PubMed

The modern day drug delivery technology is only 60years old. During this period numerous drug delivery systems have been developed. The first generation (1950-1980) has been very productive in developing many oral and transdermal controlled release formulations for clinical applications. On the othe …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Controlled Drug Delivery: Historical perspective for the next generation - PubMed

The History of Target-Controlled Infusion - PubMed

Target-controlled infusion (TCI) is a technique of infusing IV drugs to achieve a user-defined predicted ("target") drug concentration in a specific body compartment or tissue of interest. In this review, we describe the pharmacokinetic principles of TCI, the development of TCI systems, and technica …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

The History of Target-Controlled Infusion - PubMed

Journal of Drug Targeting Life Time Achievement Award for Prof. Robert Langer - PubMed

Journal of Drug Targeting Life Time Achievement Award for Prof. Robert Langer

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Journal of Drug Targeting Life Time Achievement Award for Prof. Robert Langer - PubMed

[How to dose correctly? An overview of debates in the United States, Great Britain and Germany (1830s to 1970s)] - PubMed

The dispute over low and high potencies is no longer current in today's homeopathy, but from the 1830s to the 1960s it played a major role in scientific discourse. The devotees of high potencies claimed to be the only true Hahnemannians, while their antagonists tried to practise a scientific, modern …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

[How to dose correctly? An overview of debates in the United States, Great Britain and Germany (1830s to 1970s)] - PubMed

Professor Jan Feijen: a pioneer in biomedical polymers and controlled drug release - PubMed

Professor Jan Feijen: a pioneer in biomedical polymers and controlled drug release

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

Professor Jan Feijen: a pioneer in biomedical polymers and controlled drug release - PubMed

The Pars Collection: a window into the past - PubMed

The Pars Collection: a window into the past

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

The Pars Collection: a window into the past - PubMed

Of fires and frying pans - PubMed

[A history of antipsychotic long-acting injections in the treatment of schizophrenia] - PubMed

From a historical perspective, this article describes the use of antipsychotic long-acting injections (LAI) in the treatment of schizophrenia, a disorder that was defined in the final years of the 19th century. An efficient treatment for schizophrenia was discovered only in 1952 with the introductio …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

[A history of antipsychotic long-acting injections in the treatment of schizophrenia] - PubMed

INSIGHTS INTO AVICENNA'S KNOWLEDGE OF GASTROINTESTINAL MEDICINE AND HIS ACCOUNT OF AN ENEMA DEVICE - PubMed

Avicenna (980-1037 AD), also known as Sheikh or-Raeis, was an Muslim philosopher, physician, surgeon, astronomer, politician, encyclopedist, and mathematician. Avicenna's writings comprise of five books, know as the Al-Qanun fi al-Tibb (The Canon of Medicine) and the canon covers a wide variety of m …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

INSIGHTS INTO AVICENNA'S KNOWLEDGE OF GASTROINTESTINAL MEDICINE AND HIS ACCOUNT OF AN ENEMA DEVICE - PubMed

The development of dose-dense adjuvant chemotherapy - PubMed

Dose-dense chemotherapy has made a significant contribution to the adjuvant treatment of breast cancer. One way of achieving dose-density is through the use of sequential therapy with noncross resistant therapies to cause cell kill in tumors composed of heterogeneous cells. Another way to achieve th …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

The development of dose-dense adjuvant chemotherapy - PubMed

15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting - PubMed

Traditionally, any drug intended for combating the tumor would distribute profoundly to other organs and tissues as lack of targeting specificity, thus resulting in limited therapeutic effects toward the tumor but severe drug-induced toxic side effects. To prevail over this obstacle of drug-induced …

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting - PubMed

23. From stealthy, controlled release polymersomes to cylinder-shaped 'filomicelles' for imaging and delivery: Original research article: Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles, 2004 - PubMed

23. From stealthy, controlled release polymersomes to cylinder-shaped 'filomicelles' for imaging and delivery: Original research article: Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles, 2004

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

23. From stealthy, controlled release polymersomes to cylinder-shaped 'filomicelles' for imaging and delivery: Original research article: Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles, 2004 - PubMed

21. pH-sensitive chitosan-based nanoparticles for protein drug delivery: oral approaches: Original research article: a novel pH-sensitive hydrogel composed of carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery, 2004 - PubMed

21. pH-sensitive chitosan-based nanoparticles for protein drug delivery: oral approaches: Original research article: a novel pH-sensitive hydrogel composed of carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery, 2004

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

21. pH-sensitive chitosan-based nanoparticles for protein drug delivery: oral approaches: Original research article: a novel pH-sensitive hydrogel composed of carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery, 2004 - PubMed

20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999) - PubMed

20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999)

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999) - PubMed

19. Targeted nanoparticles for smarter cancer therapy: Original research article: Folate receptor targeted biodegradable polymeric doxorubicin micelles, 2004 - PubMed

19. Targeted nanoparticles for smarter cancer therapy: Original research article: Folate receptor targeted biodegradable polymeric doxorubicin micelles, 2004

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

19. Targeted nanoparticles for smarter cancer therapy: Original research article: Folate receptor targeted biodegradable polymeric doxorubicin micelles, 2004 - PubMed

18. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs: reflections and commentary a decade later: Original research article: Biodegradable block copolymers for delivery and proteins water-insoluble drugs, 2001 - PubMed

18. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs: reflections and commentary a decade later: Original research article: Biodegradable block copolymers for delivery and proteins water-insoluble drugs, 2001

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

18. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs: reflections and commentary a decade later: Original research article: Biodegradable block copolymers for delivery and proteins water-insoluble drugs, 2001 - PubMed

17. Histidine based pH-responsive polymeric micelle for tumor: Original research article: Polymeric micelle for tumor pH folate-mediated targeting, 2003 - PubMed

17. Histidine based pH-responsive polymeric micelle for tumor: Original research article: Polymeric micelle for tumor pH folate-mediated targeting, 2003

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

17. Histidine based pH-responsive polymeric micelle for tumor: Original research article: Polymeric micelle for tumor pH folate-mediated targeting, 2003 - PubMed

15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003) - PubMed

15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003)

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003) - PubMed

13. From tissue engineering to therapeutic cancer vaccines: Original research article: Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, 2000 - PubMed

13. From tissue engineering to therapeutic cancer vaccines: Original research article: Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, 2000

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

13. From tissue engineering to therapeutic cancer vaccines: Original research article: Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, 2000 - PubMed

12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998) - PubMed

12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998)

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998) - PubMed

11. Biodegradable electrospun fibers as drug delivery system for local cancer treatment: a rugged path to the bright future: Original research article: Biodegradable electrospun fibers for drug delivery, 2003 - PubMed

11. Biodegradable electrospun fibers as drug delivery system for local cancer treatment: a rugged path to the bright future: Original research article: Biodegradable electrospun fibers for drug delivery, 2003

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

11. Biodegradable electrospun fibers as drug delivery system for local cancer treatment: a rugged path to the bright future: Original research article: Biodegradable electrospun fibers for drug delivery, 2003 - PubMed

10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002 - PubMed

10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002 - PubMed

9. Diagnostic and therapeutic applications of biocompatible gold nanorods: Original research article: PEG-modified gold nanorods with a stealth character for in vivo applications, 2006 - PubMed

9. Diagnostic and therapeutic applications of biocompatible gold nanorods: Original research article: PEG-modified gold nanorods with a stealth character for in vivo applications, 2006

·pubmed.ncbi.nlm.nih.gov·Feb 20, 2024

9. Diagnostic and therapeutic applications of biocompatible gold nanorods: Original research article: PEG-modified gold nanorods with a stealth character for in vivo applications, 2006 - PubMed